FDA approves expanded label for Pfizer, Astellas' prostate cancer Xtandi

The U.S. Food and Drug Administration has approved Pfizer Inc and Astellas Pharma Inc's Xtandi to treat patients with a type of prostate cancer, the companies said on Monday.

from Reuters: Company News https://ift.tt/2Ps4LTZ
via IFTTT